206 related articles for article (PubMed ID: 34144027)
1. Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.
Liu CZ; Mottinelli M; Nicholson HE; McVeigh BM; Wong NK; McCurdy CR; Bowen WD
Eur J Pharmacol; 2021 Sep; 906():174263. PubMed ID: 34144027
[TBL] [Abstract][Full Text] [Related]
2. Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[
Nicholson HE; Alsharif WF; Comeau AB; Mesangeau C; Intagliata S; Mottinelli M; McCurdy CR; Bowen WD
J Pharmacol Exp Ther; 2019 Feb; 368(2):272-281. PubMed ID: 30530624
[TBL] [Abstract][Full Text] [Related]
3. Characterization of CM572, a Selective Irreversible Partial Agonist of the Sigma-2 Receptor with Antitumor Activity.
Nicholson H; Comeau A; Mesangeau C; McCurdy CR; Bowen WD
J Pharmacol Exp Ther; 2015 Aug; 354(2):203-12. PubMed ID: 26034081
[TBL] [Abstract][Full Text] [Related]
4. Sigma-2 Receptors Play a Role in Cellular Metabolism: Stimulation of Glycolytic Hallmarks by CM764 in Human SK-N-SH Neuroblastoma.
Nicholson H; Mesangeau C; McCurdy CR; Bowen WD
J Pharmacol Exp Ther; 2016 Feb; 356(2):232-43. PubMed ID: 26574517
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.
Kaushal N; Robson MJ; Rosen A; McCurdy CR; Matsumoto RR
Eur J Pharmacol; 2014 Feb; 724():193-203. PubMed ID: 24380829
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents.
Kaushal N; Robson MJ; Vinnakota H; Narayanan S; Avery BA; McCurdy CR; Matsumoto RR
AAPS J; 2011 Sep; 13(3):336-46. PubMed ID: 21494909
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.
Kaushal N; Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
Eur Neuropsychopharmacol; 2013 Aug; 23(8):960-71. PubMed ID: 22921523
[TBL] [Abstract][Full Text] [Related]
8. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 1. 3-(omega-aminoalkyl)-1H-indoles.
Perregaard J; Moltzen EK; Meier E; Sánchez C
J Med Chem; 1995 May; 38(11):1998-2008. PubMed ID: 7783131
[TBL] [Abstract][Full Text] [Related]
9. Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site.
Zampieri D; Grazia Mamolo M; Laurini E; Zanette C; Florio C; Collina S; Rossi D; Azzolina O; Vio L
Eur J Med Chem; 2009 Jan; 44(1):124-30. PubMed ID: 18440098
[TBL] [Abstract][Full Text] [Related]
10. Sigma ligands with subnanomolar affinity and preference for the sigma 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines.
Moltzen EK; Perregaard J; Meier E
J Med Chem; 1995 May; 38(11):2009-17. PubMed ID: 7783132
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro Evaluation of Novel Indole-Based Sigma Receptors Ligands.
Yarim M; Koksal M; Schepmann D; Wünsch B
Chem Biol Drug Des; 2011 Nov; 78(5):869-75. PubMed ID: 21848665
[TBL] [Abstract][Full Text] [Related]
12. Trishomocubanes: novel sigma-receptor ligands modulate amphetamine-stimulated [3H]dopamine release.
Liu X; Nuwayhid S; Christie MJ; Kassiou M; Werling LL
Eur J Pharmacol; 2001 Jun; 422(1-3):39-45. PubMed ID: 11430911
[TBL] [Abstract][Full Text] [Related]
13. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo.
Intagliata S; Sharma A; King TI; Mesangeau C; Seminerio M; Chin FT; Wilson LL; Matsumoto RR; McLaughlin JP; Avery BA; McCurdy CR
AAPS J; 2020 Jul; 22(5):94. PubMed ID: 32691179
[TBL] [Abstract][Full Text] [Related]
15. N-(4-(4-(2-Halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligands.
Saur O; Hackling AE; Perachon S; Schwartz JC; Sokoloff P; Stark H
Arch Pharm (Weinheim); 2007 Apr; 340(4):178-84. PubMed ID: 17405129
[TBL] [Abstract][Full Text] [Related]
16. TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell death.
Zeng C; Weng CC; Schneider ME; Puentes L; Riad A; Xu K; Makvandi M; Jin L; Hawkins WG; Mach RH
Cell Death Discov; 2019; 5():58. PubMed ID: 30701090
[TBL] [Abstract][Full Text] [Related]
17. Binding properties of [3H]MS-377, a novel sigma receptor ligand, to rat brain membranes.
Karasawa J; Takahashi S; Horikomi K
Eur J Pharmacol; 2000 Jul; 400(1):51-7. PubMed ID: 10913584
[TBL] [Abstract][Full Text] [Related]
18. New analogs of SYA013 as sigma-2 ligands with anticancer activity.
Asong G; Zhu XY; Bricker B; Andey T; Amissah F; Lamango N; Ablordeppey SY
Bioorg Med Chem; 2019 Jun; 27(12):2629-2636. PubMed ID: 30987780
[TBL] [Abstract][Full Text] [Related]
19. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
20. [3H]N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl)butyl]-2-methoxy-5-methylbenzamide: a novel sigma-2 receptor probe.
Xu J; Tu Z; Jones LA; Vangveravong S; Wheeler KT; Mach RH
Eur J Pharmacol; 2005 Nov; 525(1-3):8-17. PubMed ID: 16289030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
